On June 13, the Centers for Disease Control and Prevention (CDC) issued a Health Alert Network (HAN) Health Advisory in response to a federal health care fraud indictment against Done Global Inc., a telehealth company based in California. The alert was aimed at informing the public about potential disruptions in access to care for individuals who rely on prescription stimulant medications, as well as the increased risks of injury and overdose that could result from this situation.
The Department of Justice (DOJ) announced the arrest of Done Global’s Founder and CEO Ruthia He, as well as Clinical President David Brody, for their alleged involvement in a $100 million scheme to defraud customers by distributing prescription stimulant medications. The scheme involved providing easy access to stimulants through deceptive advertising on social media and other means, according to the DOJ.
The CDC stated that the disruption involving this large telehealth company could affect up to 30,000 to 50,000 patients aged 18 years and older across all 50 U.S. states. This news serves as a warning to individuals who rely on prescription stimulants to take precautions and seek alternative sources for their medications during this period of uncertainty.
It is essential for the public to prioritize their health and safety in light of this situation. The CDC recommends that patients consult with their healthcare providers before making any changes to their medication regimen during this time of uncertainty. Additionally, patients should be vigilant about monitoring any symptoms or side effects related to their medication use.
The DOJ’s investigation into Done Global highlights the need for greater oversight of telehealth companies operating within the United States. As these companies continue to grow in popularity, it is crucial that they adhere to ethical standards and maintain transparency with their customers.
In conclusion, individuals who rely on prescription stimulant medications should take precautions during this period of uncertainty while seeking alternative sources for their medications. The CDC advises patients to consult with their healthcare providers before making any changes to their medication regimen. Additionally, it is important that telehealth companies adhere to ethical standards and maintain transparency with their customers.
